These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 18668535)

  • 41. Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator.
    Terkeltaub RA; Schumacher HR; Carter JD; Baraf HS; Evans RR; Wang J; King-Davis S; Weinstein SP
    Arthritis Res Ther; 2013 Feb; 15(1):R25. PubMed ID: 23375025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome.
    Hoffman HM; Mueller JL; Broide DH; Wanderer AA; Kolodner RD
    Nat Genet; 2001 Nov; 29(3):301-5. PubMed ID: 11687797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hereditary periodic fever and reactive amyloidosis.
    van der Hilst JC; Simon A; Drenth JP
    Clin Exp Med; 2005 Oct; 5(3):87-98. PubMed ID: 16284730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AA amyloidosis complicating cryopyrin-associated periodic syndrome: a study of 86 cases including 23 French patients and systematic review.
    Rodrigues F; Cuisset L; Cador-Rousseau B; Giurgea I; Neven B; Buob D; Quartier P; Hachulla E; Lequerré T; Cam G; Boursier G; Hervieu V; Grateau G; Georgin-Lavialle S
    Rheumatology (Oxford); 2022 Nov; 61(12):4827-4834. PubMed ID: 35262642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience.
    Russo RA; Melo-Gomes S; Lachmann HJ; Wynne K; Rajput K; Eleftheriou D; Edelsten C; Hawkins PN; Brogan PA
    Rheumatology (Oxford); 2014 Apr; 53(4):665-70. PubMed ID: 24352339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders.
    Arnold DD; Yalamanoglu A; Boyman O
    Front Immunol; 2022; 13():888392. PubMed ID: 35874710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene.
    Iida Y; Wakiguchi H; Okazaki F; Nakamura T; Yasudo H; Kubo M; Sugahara K; Yamashita H; Suehiro Y; Okayama N; Hashimoto K; Iwamoto N; Kawakami A; Aoki Y; Takada H; Ohga S; Hasegawa S
    Clin Rheumatol; 2019 Mar; 38(3):943-948. PubMed ID: 30338413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept.
    Lin D; Klein A; Cella D; Beutler A; Fang F; Magestro M; Cremer P; LeWinter MM; Luis SA; Abbate A; Ertel A; Litcher-Kelly L; Klooster B; Paolini JF
    BMC Cardiovasc Disord; 2021 Apr; 21(1):201. PubMed ID: 33882846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unified Modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes.
    Bozkurt Y; Demir A; Erman B; Gül A
    Comput Math Methods Med; 2015; 2015():893507. PubMed ID: 26161132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS).
    Ramos E; Aróstegui JI; Campuzano S; Rius J; Bousoño C; Yagüe J
    Rheumatology (Oxford); 2005 Aug; 44(8):1072-3. PubMed ID: 15840596
    [No Abstract]   [Full Text] [Related]  

  • 51. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes.
    Dodé C; Le Dû N; Cuisset L; Letourneur F; Berthelot JM; Vaudour G; Meyrier A; Watts RA; Scott DG; Nicholls A; Granel B; Frances C; Garcier F; Edery P; Boulinguez S; Domergues JP; Delpech M; Grateau G
    Am J Hum Genet; 2002 Jun; 70(6):1498-506. PubMed ID: 11992256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid and Sustained Long-Term Efficacy and Safety of Canakinumab in Patients With Cryopyrin-Associated Periodic Syndrome Ages Five Years and Younger.
    Brogan PA; Hofer M; Kuemmerle-Deschner JB; Koné-Paut I; Roesler J; Kallinich T; Horneff G; Calvo Penadés I; Sevilla-Perez B; Goffin L; Lauwerys BR; Lachmann HJ; Uziel Y; Wei X; Laxer RM
    Arthritis Rheumatol; 2019 Nov; 71(11):1955-1963. PubMed ID: 31161734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis.
    Aganna E; Martinon F; Hawkins PN; Ross JB; Swan DC; Booth DR; Lachmann HJ; Bybee A; Gaudet R; Woo P; Feighery C; Cotter FE; Thome M; Hitman GA; Tschopp J; McDermott MF
    Arthritis Rheum; 2002 Sep; 46(9):2445-52. PubMed ID: 12355493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model.
    Aksentijevich I; Putnam CD; Remmers EF; Mueller JL; Le J; Kolodner RD; Moak Z; Chuang M; Austin F; Goldbach-Mansky R; Hoffman HM; Kastner DL
    Arthritis Rheum; 2007 Apr; 56(4):1273-1285. PubMed ID: 17393462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of interleukin-1 with rilonacept is not effective in cold urticaria-Results of a randomized, placebo-controlled study.
    Bonnekoh H; Butze M; Spittler S; Staubach P; Weller K; Scheffel J; Maurer M; Krause K
    Clin Transl Allergy; 2023 Mar; 13(3):e12226. PubMed ID: 36973954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The familial Mediterranean fever (FMF) 50 score: does it work in a controlled clinical trial? Re-analysis of the trial of rilonacept for patients with colchicine-resistant or intolerant FMF.
    Hashkes PJ; Huang B
    Isr Med Assoc J; 2015 Mar; 17(3):137-40. PubMed ID: 25946762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes.
    Yadlapati S; Efthimiou P
    Mod Rheumatol; 2016; 26(1):3-8. PubMed ID: 26140469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cryopyrin-associated periodic fever syndrome in children: A case-based review.
    Gupta A; Tripathy SK; Phulware RH; Arava S; Bagri NK
    Int J Rheum Dis; 2020 Feb; 23(2):262-270. PubMed ID: 31858722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist.
    Hoffman HM; Rosengren S; Boyle DL; Cho JY; Nayar J; Mueller JL; Anderson JP; Wanderer AA; Firestein GS
    Lancet; 2004 Nov 13-19; 364(9447):1779-85. PubMed ID: 15541451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New drugs: methylnaltrexone bromide, alvimopan, and rilonacept.
    Hussar DA
    J Am Pharm Assoc (2003); 2008; 48(5):688-91. PubMed ID: 18826910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.